In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 188 for your search:
Drug:  topotecan hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 365 days to 20 years
Sponsor: NCI
Protocol IDs: POG-9340-42, POG-9340, POG-9341, POG-9342

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000306463, GOG-0204, NCT00064077

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-03087, TLK-286.3017, NCT00078884

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: RET5, P01CA023099, NCT00186888

6.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: Under 21
Sponsor: Other
Protocol IDs: CCLG-EPSSG-RMS-2005, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 3104000, NCT00437307

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0531, COG-ANBL0531, CDR0000554708, NCT00499616

9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KTN32313R, NCT00477282

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 1 to 29
Sponsor: NCI
Protocol IDs: NCI-2009-00369, AEWS0521, U10CA098543, COG-AEWS0521, NCT00516295

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMR PH GL 2007 CL001, NCT00547651

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0532, COG-ANBL0532, CDR0000576571, NCT00567567

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01084, CDR0000628746, GOG-0240, U10CA027469, NCT00803062

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: OV16, CAN-NCIC-OV16, EORTC-55012, GEICO-0101, CDR0000069129, NCT00028743

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MO22224, 2009-011400-33, NCT00976911

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: IFG-01-0106, NCT01405235

17.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-OVRY-002, NCT00179712

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: No age specified
Sponsor: Other
Protocol IDs: 2003-0322, NCT00317772

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AT-101-CS-101, NCT00397293

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CT/06.14, NCT00429559

21.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00252, 07-082, CDR0000561779, MSKCC-07082, 7937, NCT00521144

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12733, NCT00325416

23.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000626790, ARCAGY-GINECO-CE102, ARCAGY-HYCAR, INCA-RECF0757, EUDRACT-2008-001842-19, GINECO CE102, NCT00807079

24.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 1 month and over
Sponsor: Other
Protocol IDs: RTB1, NCT00901238

25.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000066429, UARIZ-HSC-97148, ALZA-97-017-ii, NCI-V98-1454, NCT00003415
1     
New Search